favipiravir - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 all comers	COVID-19 mild to moderate

	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate
favipiravir	Udwadia AVIFAVIR	Chang Chen et al. NCT04310228-FAVI ... Lou ...	FACCT Trial NCT04542694 Dabbous HM Udwadia Ruzhentsova T Solaymani-Dodaran AVIFAVIR Shinkai

14 studies excluded by filtering options 0

4861	Cai -FAVIPIRAVIR, 2020	1	31	0		not a RCT	risk of bias not avaialble
4980	jRCTs041190120, 2020	1	1	3			high risk of bias
6184	Erdem, 2020	2	11	0	excluded	not a RCT	risk of bias not avaialble
6244	Holubar M, 2021	1	1	0			risk of bias not avaialble
6246	IRCT20150808023559N20, 0	0	1	0	selection pending
6248	IRCT20151227025726N14 // U07, 0	0	1	0	selection pending
6252	NCT04376814-Group A, 2020	0	31	0	selection pending
6255	IRCT20200428047228N1 // U07, 0	0	1	0	selection pending
6262	Yamamura, 2020	2	30	0	excluded	not a RCT	risk of bias not avaialble
6263	Calik, 2020	1	10	4		not a RCT	high risk of bias
6265	Shenoy S, 2021	1	1	3			high risk of bias
6267	Murohashi, 2020	2	10	0	excluded	not a RCT	risk of bias not avaialble
6287	Kocayigit H, 2020	1	10	0		not a RCT	risk of bias not avaialble
6526	Dabbous, 2021	2	1	3	excluded		high risk of bias